J Korean Soc Biol Psychiatry.  1999 Jul;6(1):34-40.

Beyond the SSRIs

Abstract

New antidepressants have become available for clinical use in the 1990s. Before this decade, the drugs available to treat depression consisted essentially of monoamine oxidase inhibitors, tricyclic antidepressants, and lithium. Following the introduction of SSRIs, the options have expanded and now include SSRIs nefazodone, venlafaxine, mirtazapine, reboxetine, tianeptine. Newer antidepressants possess a variety of pharmacological characteristics that are relevant to the choice of an antidepressant for clinical use. This review summarizes some of the major pharmacological characteristics among the drugs.


MeSH Terms

Antidepressive Agents
Antidepressive Agents, Tricyclic
Depression
Lithium
Monoamine Oxidase Inhibitors
Venlafaxine Hydrochloride
Antidepressive Agents
Antidepressive Agents, Tricyclic
Lithium
Monoamine Oxidase Inhibitors
Full Text Links
  • JKJBP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr